MAPT and Alzheimer disease: As the precise, mechanistic roles of amyloid-beta and tau aggregates in the pathogenesis of AD remain unclear, CARPs could also be beneficial by mitigating the cellular effects of cytotoxic amyloids, rather than preventing the formation of aggregates per se.